1. Search Result
Search Result
Results for "

Tilomisole

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-106050
    Tilomisole

    Wy 18251

    Others Cancer Inflammation/Immunology
    Tilomisole (Wy 18251) is a benzimidazothiazole experimental drug with anti-inflammatory activity. Tilomisole causes less agranulocytosis than levamisole, but retains immunomodulating capabilities. Tilomisole is orally active. Tilomisole has the potential for the research of cancer and inflammation.
  • HY-115922
    Anti-inflammatory agent 10

    COX Inflammation/Immunology
    Anti-inflammatory agent 10 (compound 30) is a tilomisole-based benzimidazothiazole derivative. Anti-inflammatory agent 10 expresses activity on COX-2 enzyme more than COX-1. Anti-inflammatory agent 10 is orally active.
  • HY-115921
    Anti-inflammatory agent 9

    COX Inflammation/Immunology
    Anti-inflammatory agent 9 (compound 28) is a tilomisole-based benzimidazothiazole derivative. Anti-inflammatory agent 9 expresses activity on COX-2 enzyme more than COX-1. Anti-inflammatory agent 9 is orally active.
  • HY-115920
    Anti-inflammatory agent 8

    COX Inflammation/Immunology
    Anti-inflammatory agent 8 (compound 13) is a tilomisole-based benzimidazothiazole derivative. Anti-inflammatory agent 8 expresses activity on COX-2 enzyme more than COX-1 with an IC50 of 0.09 nM. Anti-inflammatory agent 8 is orally active.